62 related articles for article (PubMed ID: 10582694)
21. Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation.
Gravina GL; Festuccia C; Marampon F; Popov VM; Pestell RG; Zani BM; Tombolini V
Mol Cancer; 2010 Nov; 9():305. PubMed ID: 21108789
[TBL] [Abstract][Full Text] [Related]
22. Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions.
Jedlicka P
Int J Clin Exp Pathol; 2010 Mar; 3(4):338-47. PubMed ID: 20490326
[TBL] [Abstract][Full Text] [Related]
23. Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation.
Tirado OM; MacCarthy CM; Fatima N; Villar J; Mateo-Lozano S; Notario V
Int J Cancer; 2010 Jan; 126(2):426-36. PubMed ID: 19609943
[TBL] [Abstract][Full Text] [Related]
24. Development of IGF-IR Inhibitors in Pediatric Sarcomas.
Kolb EA; Gorlick R
Curr Oncol Rep; 2009 Jul; 11(4):307-13. PubMed ID: 19508836
[TBL] [Abstract][Full Text] [Related]
25. The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications.
Arcaro A; Guerreiro AS
Curr Genomics; 2007 Aug; 8(5):271-306. PubMed ID: 19384426
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma.
Yamamoto T; Ohno T; Wakahara K; Nagano A; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Shimizu K
J Cancer Res Clin Oncol; 2009 Aug; 135(8):1125-36. PubMed ID: 19205734
[TBL] [Abstract][Full Text] [Related]
27. The role of IGF-1R in pediatric malignancies.
Kim SY; Toretsky JA; Scher D; Helman LJ
Oncologist; 2009 Jan; 14(1):83-91. PubMed ID: 19126579
[TBL] [Abstract][Full Text] [Related]
28. Molecular approaches to sarcoma therapy.
Olsen RJ; Tarantolo SR; Hinrichs SH
Sarcoma; 2002; 6(1):27-42. PubMed ID: 18521343
[TBL] [Abstract][Full Text] [Related]
29. Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway.
Krishnan K; Bruce B; Hewitt S; Thomas D; Khanna C; Helman LJ
Clin Exp Metastasis; 2006; 23(3-4):227-36. PubMed ID: 17028919
[TBL] [Abstract][Full Text] [Related]
30. Akt versus p53 in a network of oncogenes and tumor suppressor genes regulating cell survival and death.
Wee KB; Aguda BD
Biophys J; 2006 Aug; 91(3):857-65. PubMed ID: 16648169
[TBL] [Abstract][Full Text] [Related]
31. The potential for molecular therapeutic targets in Ewing's sarcoma.
McAllister NR; Lessnick SL
Curr Treat Options Oncol; 2005 Nov; 6(6):461-71. PubMed ID: 16242051
[TBL] [Abstract][Full Text] [Related]
32. Ewing's sarcoma family of tumors.
Antuña García MJ
Clin Transl Oncol; 2005 Jul; 7(6):262-9. PubMed ID: 16131451
[No Abstract] [Full Text] [Related]
33. PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death.
Hotfilder M; Sondermann P; Senss A; van Valen F; Jürgens H; Vormoor J
Br J Cancer; 2005 Feb; 92(4):705-10. PubMed ID: 15685229
[TBL] [Abstract][Full Text] [Related]
34. Alteration of mesodermal cell differentiation by EWS/FLI-1, the oncogene implicated in Ewing's sarcoma.
Eliazer S; Spencer J; Ye D; Olson E; Ilaria RL
Mol Cell Biol; 2003 Jan; 23(2):482-92. PubMed ID: 12509448
[TBL] [Abstract][Full Text] [Related]
35. Ewing tumour: incidence, prognosis and treatment options.
Paulussen M; Fröhlich B; Jürgens H
Paediatr Drugs; 2001; 3(12):899-913. PubMed ID: 11772151
[TBL] [Abstract][Full Text] [Related]
36. Phosphoinositide 3-hydroxide kinase blockade enhances apoptosis in the Ewing's sarcoma family of tumors.
Toretsky JA; Thakar M; Eskenazi AE; Frantz CN
Cancer Res; 1999 Nov; 59(22):5745-50. PubMed ID: 10582694
[TBL] [Abstract][Full Text] [Related]
37. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
Chandrasekher G; Sailaja D
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
[TBL] [Abstract][Full Text] [Related]
38. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
Tu Y; Gardner A; Lichtenstein A
Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
[TBL] [Abstract][Full Text] [Related]
39. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
40. PI3K/Akt signalling pathway and cancer.
Fresno Vara JA; Casado E; de Castro J; Cejas P; Belda-Iniesta C; González-Barón M
Cancer Treat Rev; 2004 Apr; 30(2):193-204. PubMed ID: 15023437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
